Career Shorts: Li Zhou, What excites you about the world of antibody discovery?

This short is an excerpt from the full Career Shorts Ep 1 with Dr Li Zhou, principle scientist at AbbVie. This series is hosted by the Antibody Society as a series where we talk to scientists and individuals working within the world of antibodies about the experiences that have shaped their careers and have got them to where they are today. Our goal by sharing their experiences and advice is to empower the next generation of scientists and leaders working in this field and beyond to make confident and empowered decisions.

About The Antibody Society:
The Antibody Society is an international, non-profit association representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field. We are: - Creating opportunities for education and networking; - Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics; - Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field; - Engaging government and international agencies on matters concerning the antibody community.

We encourage you to join the 2,200+ members of The Antibody Society to take advantage of the substantial benefits of membership, including discounts on fees for selected Informa Connect, CHI, and Hanson Wade meetings and access to information in the Members Only section of the website.

In particular, we encourage members to take advantage of the discount on registration for Antibody Engineering & Therapeutics, which is the annual meeting of The Antibody Society traditionally held in San Diego in December.

Social Media:
Twitter: @TheAbSociety

#careers #PhDlife #PhDchats #PhD #postdocs #careeradvice #careerdevelopment #antibodies #antibody #science #biotech #lifescience

About Li:
Li Zhou is a principal scientist at AbbVie operation S &T Protein Analytics and an assistant editor of mAbs. At Abbvie, he works on all aspects of biologics analytical development from R and D transition to commercial launch. Prior to this role, he has five years of experience working on over 70 drug discovery projects spanning immunology, oncology, neuroscience and virology and has served as biologics lead with external partners for co-developing conditional biologics. Li obtained his PhD in chemistry with professor Adrian Whitty at Boston University and regulatory affair certification in US. Since joining AbbVie in 2015, he has authored 8 peer-reviewed publications (4 as lead author) including JBC, mAbs, analytical chemistry.